Treatment complications in children with lyme meningitis

Pediatric Infectious Disease Journal

Volumn 31, Issue 10, 2012, Pages 1032-1035

  Thompson, Amy D ^a   Cohn, Keri A ^b   Shah, Samir S ^c   Lyons, Todd ^b   Welsh, Elizabeth J ^b   Hines, Elizabeth M ^d   Nigrovic, Lise E ^b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lyme disease; meningitis; peripherally inserted central catheter

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD DISEASE; CHOLELITHIASIS; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DRUG ERUPTION; DRUG FEVER; EMERGENCY WARD; FEMALE; FOLLOW UP; HUMAN; INFECTIOUS COMPLICATION; LYME DISEASE; LYME MENINGITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PHLEBITIS; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG TOXICITY; FEMALE; HUMANS; INFANT; LYME DISEASE; MALE; MENINGITIS, BACTERIAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84866632575     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31825eb3c7     Document Type: Article

References (42)

1. Krbkova L, Stanek G. Therapy of Lyme borreliosis in children. Infection. 1996;24:170-173.
2. Wormser G P, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-1134.
3. Halperin JJ, Shapiro ED, Logigian E, et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69:91-102.
4. Millner MM, Müllegger RR, Spork KD, et al. Lyme borreliosis of central nervous system (CNS) in children: a diagnostic challenge. Infection. 1991;19:273-278.
5. Müllegger RR, Millner MM, Stanek G, et al. Penicillin G sodium and ceftri-axone in the treatment of neuroborreliosis in children-a prospective study. Infection. 1991;19:279-283.
6. American Academy of Pediatrics. Lyme Disease. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:430-435.
7. Wormser G P. Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination. Semin Neurol. 1997;17:45-52.
8. Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis. 2005;37:449-454.
9. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7:690-695.
10. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxy-cycline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337:289-294.
11. Cohn KA, Thompson AD, Shah SS, et al. Multi-center validation of a clinical decision rule to distinguish Lyme from aseptic meningitis Pediatrics. 2012;129:e46-e53.
12. Rubenstein JS, Yogev R. What represents pleocytosis in blood-contaminated ("traumatic tap") cerebrospinal fuid in children? J Pediatr. 1985;107: 249-251.
13. Mayefsky JH, Roghmann KJ. Determination of leukocytosis in traumatic spinal tap specimens. Am J Med. 1987;82:1175-1181.
14. Bacon RM, Kugele PS. Surviellance for Lyme Disease\United States 1992-2006. MMWR Surveill Summ. 2008;57:1-9.
15. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44:590-591.
16. Steere AC, McHugh G, Damle N, et al. Prospective study of serologic tests for lyme disease. Clin Infect Dis. 2008;47:188-195.
17. Nadelman RB, Wormser G P. Reinfection in patients with Lyme disease. Clin Infect Dis. 2007;45:1032-1038.
18. Levy I, Bendet M, Samra Z, et al. Infectious complications of peripherally inserted central venous catheters in children. Pediatr Infect Dis J. 2010;29:426-429.
19. Bourgeois FC, Lamagna P, Chiang VW. Peripherally inserted central catheters. Pediatric emergency care. 2011;27:556-561; quiz 562-553.
20. Ruebner R, Keren R, Coffn S, et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. 2006;117:1210-1215.
21. Thiagarajan RR, Ramamoorthy C, Gettmann T, et al. Survey of the use of peripherally inserted central venous catheters in children. Pediatrics. 1997;99:E4.
22. Van Winkle P, Whiffen T, Liu IL. Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital. Pediatr Infect Dis J. 2008;27:1069-1072.
23. Chow LM, Friedman JN, Macarthur C, et al. Peripherally inserted central catheter (PICC) fracture and embolization in the pediatric population. J Pediatr. 2003;142:141-144.
24. Maraqa NF, Gomez MM, Rathore MH. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children. J Pediatr Orthop. 2002;22:506-510.
25. Hussain S, Gomez MM, Wludyka P, et al. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila). 2007;46:247-251.
26. Frey AM, Schears GJ. Why are we stuck on tape and suture? A review of catheter securement devices. J Infus Nurs. 2006;29:34-38.
27. O'Grady N P, Alexander M, Burns LA, et al.; Healthcare Infection Control Practices Advisory Committee (HICPAC) (Appendix 1). Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:1087-1099.
28. O'Grady N P, Alexander M, Burns LA, et al.; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:e162-e193.
29. Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of lyme bor-reliosis. Clin Microbiol Rev. 2005;18:484-509.
30. Oksi J, Nikoskelainen J, Hiekkanen H, et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis. 2007;26:571-581.
31. Karkkonen K, Stiernstedt SH, Karlsson M. Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis. 2001;33:259-262.
32. Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocy-cline. Clin Pharmacokinet. 1988;15:355-366.
33. Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neurobor-reliosis. Neurolog y. 1994;44:1203-1207.
34. Dotevall L, Alestig K, Hanner P, et al. The use of doxycycline in nervous system Borrelia burgdorferi infection. Scand J Infect Dis Suppl. 1988;53:74-79.
35. Sicklinger M, Wienecke R, Neubert U. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. J Clin Microbiol. 2003;41:1791-1793.
36. Hunfeld K P, Brade V. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Wien Klin Wochenschr. 2006;118:659-668.
37. Feder HM Jr, Gerber MA, Luger SW, et al. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis. 1992;15:788-793.
38. Kalish RA, McHugh G, Granquist J, et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33:780-785.
39. Sivak SL, Aguero-Rosenfeld ME, Nowakowski J, et al. Accuracy of IgM immunoblotting to confrm the clinical diagnosis of early Lyme disease. Arch Intern Med. 1996;156:2105-2109.
40. Porwancher R. A reanalysis of IgM Western blot criteria for the diagnosis of early Lyme disease. J Infect Dis. 1999;179:1021-1024.
41. Weinstein A. Editorial commentary: laboratory testing for Lyme disease: time for a change? Clin Infect Dis. 2008;47:196-197.
42. Wormser G P, Halperin JJ. Oral doxycycline for neuroborreliosis. Lancet Neurol. 2008;7:665-666.